Michal Abrahamowicz
Research Scientist, Biostatistics, PhD
Appointments
- James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
- Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre
Research Interests
- Biostatistics
- Survival analysis
- Pharmacoepidemiology
- Clinical epidemiology
- Epidemiologic methods
- Longitudinal analysis
- Non-communicable disease epidemiology
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.
His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).Learn more
Recent News Coverage

People with Autoimmune Arthritis at Greater Risk of Severe COVID
Arthritis Research Canada researchers find that people with autoimmune rheumatic diseases and transplant recipients face a heightened risk of complications from COVID-19.

Questioning the Impact of Wearable Tech on People with Rheumatoid Arthritis
Researchers investigate the impact of using wearable tech (like Fitbits) in research on participants’ feelings of self-worth and the relationship with their health care provider.

Surgery Not the Only Option for People with Knee Osteoarthritis
Arthritis Research Canada researchers examined the actual use of non-surgical treatments and services like education, exercise, weight management, and pain medications by people with knee osteoarthritis.

Online Decision Aid Helps Patients Weigh Risks and Benefits of Surgery vs. Other Treatments
A research team led by Arthritis Research Canada scientists has developed an online tool, called a decision aid, that provides individualized information on total knee replacement surgery and non-surgical treatment options to people with knee osteoarthritis.

Alberta in Need of More Resources for Rural Residents with Osteoarthritis
Alberta is in need of more resources to improve access to healthcare for rural residents with osteoarthritis.

Researchers Point to Lifestyle Changes to Help Prevent Lupus
Study finds healthy lifestyle behaviours can help to prevent lupus for those who may be genetically predisposed, and emphasizes the importance of proper screening for this chronic disease.

New Research Ties Rare Inflammatory Disease to Increased Risk of Cardiovascular Disease
Study finds people with a rare inflammatory disease, known as granulomatosis with polyangiitis, have an increased risk of serious, life-threatening blood clots.

Study Finds Rheumatoid Arthritis Patients Better Off with Ongoing Rheumatology Care
Study finds room for improvement when it comes to keeping rheumatoid arthritis patients under the care of a rheumatologist long term.

BC Government Announces $3 Million for Arthritis Research at ARThritis Soirée
Arthritis Research Canada reaches $3,375,000+ at annual ARThritis Soirée following big funding announcement by Health Minister Adrian Dix.

More Support Needed for Patients with Rheumatoid Arthritis Looking to Start Families
New study highlights need for more support for female patients with rheumatoid arthritis and their partners when it comes to family planning and reproductive decisions.